chartexchange

TSHA
Taysha Gene Therapies, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 9:41:08 AM EST
4.05USD+1.378%(+0.06)144,321
4.0400Bid4.0500Ask0.0100Spread

TSHA Financials

In Q3 FY 2026 (ended ), Taysha Gene Therapies, Inc. Common Stock (TSHA) reported revenue of $0, net income of −$39.13M, operating cash flow of −$32.91M, and assets of $435.03M (filed ).

Loading financial statements…